Historical record - last NADAC effective date: 3/22/2023
Product Information
ENOXAPARIN 120 MG/0.8 ML SYR is a generic product labeled by Fresenius Kabi USA, LLC, priced at $14.8986 per ML under NDC 63323060990. Its NADAC has been published 128 times since Oct 21, 2020.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AP.
Strength
120 mg/.8mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323060990
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
3/22/2023
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020164FDA Approved
3/29/1993
TE Code
AP
On Market Since
6/18/2019
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 120 MG/0.8 ML SYR has been published 128 times since Oct 21, 2020, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.8986 per ML |
|---|---|
| All-time high | $18.8634 (Nov 16, 2022) |
| All-time low | $13.9870 (Jan 18, 2023) |
| Median price | $15.4006 |
| Average price | $15.7080 |
| Largest weekly change | +30.1% (May 18, 2022) |
| Weeks tracked | 128 |
| Tracking since | Oct 21, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-3.7%
All
+4.6%
Last surveyed Mar 29, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
enoxaparin sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Low Molecular Weight Heparin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 120 MG/0.8 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 120 MG/0.8 ML SYR, manufactured by Fresenius Kabi USA, LLC, is $14.8986 per ML (NDC 63323060990), effective Mar 29, 2023.
How has the price of ENOXAPARIN 120 MG/0.8 ML SYR changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 120 MG/0.8 ML SYR has risen 4.6%. It has been tracked across 128 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 120 MG/0.8 ML SYR?
Since Oct 21, 2020, the NADAC for ENOXAPARIN 120 MG/0.8 ML SYR has ranged from a low of $13.9870 (Jan 18, 2023) to a high of $18.8634 (Nov 16, 2022), with a median of $15.4006 per ML.
Are there cheaper alternatives to ENOXAPARIN 120 MG/0.8 ML SYR?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENOXAPARIN 120 MG/0.8 ML SYR, is $10.4173 per ML — about 30% below ENOXAPARIN 120 MG/0.8 ML SYR.
Who manufactures ENOXAPARIN 120 MG/0.8 ML SYR?
ENOXAPARIN 120 MG/0.8 ML SYR (NDC 63323060990) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.